![](/img/cover-not-exists.png)
P522 Soluble sMadCAM1 and retinoic acid are potential tools for therapeutic drug monitoring in inflammatory bowel disease s under vedolizumab: A proof of concept
Roblin, X, Williet, N, Boschetti, G, Flourie, B, Del Tedesco, E, Peyrin Biroulet, L, Phelip, J m, Nancey, S, Paul, SVolume:
12
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx180.649
Date:
January, 2018
File:
PDF, 231 KB
english, 2018